{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:32:45Z","timestamp":1791873165746,"version":"4.3.4"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2017,5,2]],"date-time":"2017-05-02T00:00:00Z","timestamp":1493683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100004828","name":"Grand Challenges Canada","doi-asserted-by":"publisher","award":["0199-01"],"award-info":[{"award-number":["0199-01"]}],"id":[{"id":"10.13039\/501100004828","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>OBJECTIVES<\/jats:title>\n                  <jats:p>African and African American hypertensives tend to retain salt and water, with lower levels of plasma renin and more resistant hypertension. We tested the hypothesis that physiological phenotyping with plasma renin and aldosterone would improve blood pressure control in uncontrolled hypertensives in Africa.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>Patients at hypertension clinics in Nigeria, Kenya, and South Africa with a systolic blood pressure &amp;gt;140 mm Hg or diastolic pressure &amp;gt; 90 mm Hg despite treatment were allocated to usual care (UC) vs. physiologically individualized care (PhysRx). Plasma renin activity and aldosterone were measured using ELISA kits. Patients were followed for 1 year; the primary outcome was the percentage of patients achieving blood pressure &amp;lt;140 mm Hg and diastolic &amp;lt;90 mm Hg.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Results are presented for the 94\/105 participants who completed the study (42 UC, 52 PhysRx). Control of both systolic and diastolic pressures was obtained in 11.1% of UC vs. 50.0% of PhysRx (P = 0.0001). Systolic control was achieved in 13.9% of UC vs. 60.3% of PhysRx (P = 0.0001); diastolic control in 36.1% of UC vs. 67.2% of PhysRx, vs. (P = 0.003). Number of visits and total number of medications were not significantly different between treatment groups, but there were differences across the sites. There were important differences in prescription of amiloride as specified in the PhysRx algorithm.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Physiologically individualized therapy based on renin\/aldosterone phenotyping significantly improved blood pressure control in a sample of African patients with uncontrolled hypertension. This approach should be tested in African American and other patients with resistant hypertension.<\/jats:p>\n                  <jats:p>Registered as ISRCTN69440037<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ajh\/hpx066","type":"journal-article","created":{"date-parts":[[2017,4,12]],"date-time":"2017-04-12T19:09:41Z","timestamp":1492024181000},"page":"923-930","source":"Crossref","is-referenced-by-count":58,"title":["Physiological Phenotyping for Personalized Therapy of Uncontrolled Hypertension in Africa"],"prefix":"10.1093","volume":"30","author":[{"given":"Adeseye","family":"Akintunde","sequence":"first","affiliation":[{"name":"Ladoke Akintola University of Technology Teaching Hospital 1 , Ogbomoso, Oyo State , Nigeria ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justus","family":"Nondi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Egerton University 2 , Nakuru , Kenya ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kennedy","family":"Gogo","sequence":"additional","affiliation":[{"name":"Department of Medicine, Egerton University 2 , Nakuru , Kenya ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika S W","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Medicine, Groote Schuur Hospital, University of Cape Town 3 , Cape Town , South Africa ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian L","family":"Rayner","sequence":"additional","affiliation":[{"name":"Department of Medicine, Groote Schuur Hospital, University of Cape Town 3 , Cape Town , South Africa ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel G","family":"Hackam","sequence":"additional","affiliation":[{"name":"Departments of Medicine and Biostatistics and Epidemiology, Western University 4 , London, ON , Canada ;"},{"name":"Department of Neurology and Clinical Pharmacology, Stroke Prevention and Atherosclerosis Research Centre, Robarts Research Institute, Western University 5 , London, ON , Canada ."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J David","family":"Spence","sequence":"additional","affiliation":[{"name":"Department of Neurology and Clinical Pharmacology, Stroke Prevention and Atherosclerosis Research Centre, Robarts Research Institute, Western University 5 , London, ON , Canada ."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,5,2]]},"reference":[{"key":"2022111818051074700_CIT0001","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0002-9343(72)90054-X","article-title":"Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease","volume":"52","author":"Laragh","year":"1972","journal-title":"Am J Med"},{"key":"2022111818051074700_CIT0002","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0895-7061(99)00154-5","article-title":"Physiologic tailoring of therapy for resistant hypertension: 20 years\u2019 experience with stimulated renin profiling","volume":"12","author":"Spence","year":"1999","journal-title":"Am J Hypertens"},{"key":"2022111818051074700_CIT0003","doi-asserted-by":"crossref","first-page":"27","DOI":"10.7326\/0003-4819-82-1-27","article-title":"Stimulated renin: a screening test for hypertension","volume":"82","author":"Wallach","year":"1975","journal-title":"Ann Intern Med"},{"key":"2022111818051074700_CIT0004","article-title":"Hypertension in Blacks: insights from Africa","author":"Rayner","year":"","journal-title":"J Hypertens"},{"key":"2022111818051074700_CIT0005","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"key":"2022111818051074700_CIT0006","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1056\/NEJMp1511294","article-title":"Will precision medicine move us beyond race?","volume":"374","author":"Bonham","year":"2016","journal-title":"N Engl J Med"},{"key":"2022111818051074700_CIT0007","first-page":"213","article-title":"Physiologic tailoring of treatment in resistant hypertension","volume":"6","author":"Spence","year":"2010","journal-title":"Curr Cardiol Rev"},{"key":"2022111818051074700_CIT0008","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1161\/01.HYP.0000203771.24792.bf","article-title":"Individualized therapy for hypertension","volume":"47","author":"Spence","year":"2006","journal-title":"Hypertension"},{"key":"2022111818051074700_CIT0009","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/HJH.0000000000001171","article-title":"Hypertension in Blacks: insights from Africa","volume":"35","author":"Rayner","year":"2017","journal-title":"J Hypertens"},{"key":"2022111818051074700_CIT0010","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1161\/HYPERTENSIONAHA.114.03127","article-title":"Sensitivity to aldosterone: plasma levels are not the full story","volume":"63","author":"Funder","year":"2014","journal-title":"Hypertension"},{"key":"2022111818051074700_CIT0011","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/00001648-200301000-00029","article-title":"Salt, slavery and survival: hypertension in the African diaspora","volume":"14","author":"Grim","year":"2003","journal-title":"Epidemiology"},{"key":"2022111818051074700_CIT0012","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/ajh.2009.63","article-title":"Plasma Renin test-guided drug treatment algorithm for correcting patients with treated but uncontrolled hypertension: a randomized controlled trial","volume":"22","author":"Egan","year":"2009","journal-title":"Am J Hypertens"},{"key":"2022111818051074700_CIT0013","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1097\/00004872-200410000-00030","article-title":"The current epidemic of primary aldosteronism: causes and consequences","volume":"22","author":"Spence","year":"2004","journal-title":"J Hypertens"},{"key":"2022111818051074700_CIT0014","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.cjca.2011.11.010","article-title":"Lessons from Africa: the importance of measuring plasma renin and aldosterone in resistant hypertension","volume":"28","author":"Spence","year":"2012","journal-title":"Can J Cardiol"},{"key":"2022111818051074700_CIT0015","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1210\/jc.2009-1399","article-title":"Update in primary aldosteronism","volume":"94","author":"Stowasser","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2022111818051074700_CIT0016","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1161\/01.HYP.0000022570.02119.75","article-title":"Amiloride, a specific drug for hypertension in Black people with T594M variant?","volume":"40","author":"Baker","year":"2002","journal-title":"Hypertension"},{"key":"2022111818051074700_CIT0017","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1161\/HYPERTENSIONAHA.108.121665","article-title":"Whites excrete a water load more rapidly than Blacks","volume":"53","author":"Weder","year":"2009","journal-title":"Hypertension"},{"key":"2022111818051074700_CIT0018","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1161\/HYPERTENSIONAHA.113.02989","article-title":"Racial differences in sensitivity of blood pressure to aldosterone","volume":"63","author":"Tu","year":"2014","journal-title":"Hypertension"},{"key":"2022111818051074700_CIT0019","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1161\/01.STR.0000217222.09978.ce","article-title":"Racial and geographic differences in awareness, treatment, and control of hypertension: the REasons for Geographic And Racial Differences in Stroke study","volume":"37","author":"Howard","year":"2006","journal-title":"Stroke"},{"key":"2022111818051074700_CIT0020","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.cjca.2015.03.005","article-title":"Blood pressure control in Canada: the view from a stroke prevention clinic","volume":"31","author":"Spence","year":"2015","journal-title":"Can J Cardiol"},{"key":"2022111818051074700_CIT0021","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.gheart.2014.01.003","article-title":"The global burden of hemorrhagic stroke: a summary of findings from the GBD 2010 study","volume":"9","author":"Krishnamurthi","year":"2014","journal-title":"Glob Heart"},{"key":"2022111818051074700_CIT0022","first-page":"e29","article-title":"Heart disease and stroke statistics\u20132015 update: a report from the American Heart Association","volume":"131","author":"Mozaffarian","year":"2015","journal-title":"Circulation"},{"key":"2022111818051074700_CIT0023","first-page":"499","article-title":"Adequacy of blood pressure control and level of adherence with antihypertensive therapy","volume":"86","author":"Achieng\u2019","year":"2009","journal-title":"East Afr Med J"},{"key":"2022111818051074700_CIT0024","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1097\/00004872-200305000-00016","article-title":"A new mutation, R563Q, of the beta subunit of the epithelial sodium channel associated with low-renin, low-aldosterone hypertension","volume":"21","author":"Rayner","year":"2003","journal-title":"J Hypertens"},{"key":"2022111818051074700_CIT0025","first-page":"1286","article-title":"The association of the R563Q genotype of the ENaC with phenotypic variation in Southern Africa","volume":"25","author":"Jones","year":"2012","journal-title":"Am J Hypertens"},{"key":"2022111818051074700_CIT0026","first-page":"1","article-title":"The R563Q mutation of the epithelial sodium channel beta-subunit is associated with hypertension","volume":"21","author":"Jones","year":"2010","journal-title":"Cardiovasc J Afr"},{"key":"2022111818051074700_CIT0027","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/j.1751-7176.2010.00359.x","article-title":"High prevalence of liddle syndrome phenotype among hypertensive US Veterans in Northwest Louisiana","volume":"12","author":"Tapolyai","year":"2010","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"2022111818051074700_CIT0028","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0895-7061(03)01032-X","article-title":"Efficacy of low-dose spironolactone in subjects with resistant hypertension","volume":"16","author":"Nishizaka","year":"2003","journal-title":"Am J Hypertens"},{"key":"2022111818051074700_CIT0029","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1161\/01.HYP.0000179582.42830.1d","article-title":"Improvement in blood pressure with inhibition of the epithelial sodium channel in Blacks with hypertension","volume":"46","author":"Saha","year":"2005","journal-title":"Hypertension"},{"key":"2022111818051074700_CIT0030","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1097\/HJH.0b013e3282f254d9","article-title":"Amiloride 10 mg is less effective than spironolactone 25 mg in patients with hypertension resistant to a multidrug regime including an angiotensin-blocking agent","volume":"25","author":"Lane","year":"2007","journal-title":"J Hypertens"},{"key":"2022111818051074700_CIT0031","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jash.2014.04.011","article-title":"Genetic variation in CYP4A11 and blood pressure response to mineralocorticoid receptor antagonism or ENaC inhibition: an exploratory pilot study in African Americans","volume":"8","author":"Laffer","year":"2014","journal-title":"J Am Soc Hypertens"},{"key":"2022111818051074700_CIT0032","doi-asserted-by":"crossref","DOI":"10.1093\/ajh\/hpw167","article-title":"High frequency of variants of candidate genes in Black Africans with low renin-resistant hypertension","author":"Jones","year":"2017","journal-title":"Am J Hypertens"},{"key":"2022111818051074700_CIT0033","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.cjca.2016.02.066","article-title":"Hypertension Canada\u2019s 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension","volume":"32","author":"Leung","year":"2016","journal-title":"Can J Cardiol"},{"key":"2022111818051074700_CIT0034","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/HYPERTENSIONAHA.115.06562","article-title":"J curve and cuff artefact, and diagnostic inertia in resistant hypertension","volume":"67","author":"Spence","year":"2016","journal-title":"Hypertension"}],"container-title":["American Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajh\/article-pdf\/30\/9\/923\/47133083\/ajh_30_9_923.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajh\/article-pdf\/30\/9\/923\/47133083\/ajh_30_9_923.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T18:05:40Z","timestamp":1668794740000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajh\/article\/30\/9\/923\/3789403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,2]]},"references-count":34,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2017,5,2]]},"published-print":{"date-parts":[[2017,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ajh\/hpx066","relation":{},"ISSN":["0895-7061","1941-7225"],"issn-type":[{"value":"0895-7061","type":"print"},{"value":"1941-7225","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,9]]},"published":{"date-parts":[[2017,5,2]]}}}